A simple method for estimation of agonist activity at receptor subtypes: Comparison of native and cloned M3 muscarinic receptors in guinea pig ileum and transfected cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 2, 1999, Pages 981-992

  Ehlert, Frederick J ^a   Griffin, Michael T ^b   Sawyer, Gregory W ^c   Bailon, Regina ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHAPMAN UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

[4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; ACECLIDINE; ARECOLINE; BETHANECHOL; CARBACHOL; INOSITOL; MUSCARINIC M3 RECEPTOR; MUSCARINIC M3 RECEPTOR ANTAGONIST; OXOTREMORINE; OXOTREMORINE M; PHOSPHATIDYLINOSITIDE; PILOCARPINE; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL TISSUE; CHO CELL; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; GUINEA PIG; HYDROLYSIS; ILEUM; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; RECEPTOR AFFINITY; VALIDATION PROCESS;

ALGORITHMS; ANIMALS; CELL LINE; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; GUINEA PIGS; HYDROLYSIS; ILEUM; MUSCARINIC AGONISTS; PHOSPHATIDYLINOSITOLS; RECEPTOR, MUSCARINIC M3; RECEPTORS, MUSCARINIC; TRANSFECTION;

EID: 0032902884     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Berridge MJ, Downes CP and Hanley MR (1982) Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 206:587-595.
2. Black JW and Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond B 220:141-162.
3. Black JW, Leff P, Shankley NP and Wood J (1985) An operational model of pharmacological agonism: The effect of E/[A] curve shape on agonist dissociation constant estimation. Br J Pharmacol 84:561-571.
4. Candell LM, Yun SH, Tran LL and Ehlert FJ (1990) Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum. Mol Pharmacol 38:689-697.
5. Eglen RM, editor (1997) Muscarinic Receptor Subtypes in Smooth Muscle, CRC Press, Boca Raton.
6. Ehlert FJ (1987) Coupling of muscarinic receptors to adenylate cyclase in the rabbit myocardium: Effects of receptor inactivation. J Pharmacol Exp Ther 240:23-30.
7. Ehlert FJ, Griffin MT and Glidden PF (1996) The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor. J Pharmacol Exp Ther 279: 1335-1344.
8. Ehlert FJ, Thomas EA, Gerstin EH and Griffin MT (1997) Muscarinic receptors and gastrointestinal smooth muscle, in Muscarinic Receptor Subtypes in Smooth Muscle (Eglen RM ed), pp 92-147, CRC Press, Boca Raton.
9. Ehlert FJ and Yamamura HI (1995) Pharmacological analysis of muscarinic receptor-mediated inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis, in Molecular Mechanisms of Muscarinic Acetylcholine Receptor Function (Wess J ed) pp 47-69, R. G. Landes Company, Austin, TX.
10. Eltze M, Ullrich B, Mutschler E, Moser U, Bungardt E, Friebe T, Gubitz C, Tacke R and Lambrecht G (1993) Characterization of muscarinic receptors mediating vasodilation in rat perfused kidney. Eur J Pharmacol 238:343-355.
11. Furchgott RF (1966) The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. Adv Drug Res 3:21-55.
12. Furchgott RF and Bursztyn P (1967) Comparison of dissociation constants and of relative efficacies of selected agonists acting on parasympathetic receptors. Ann NY Acad Sci 144:882-899.
13. Jones A (1963) Ganglionic actions of muscarinic substances. J Pharmacol Exp Ther 195:195-205.
14. Kenakin TP and Beek D (1982) In vitro studies on the cardiac activity of prenalterol with reference to use in congestive heart failure. J Pharmacol Exp Ther 220:77-85.
15. Lazareno S, Farries T and Birdsall NJ (1993) Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors m1-m4. Life Sci 52:449-456.
16. Leff P, Scaramellini C, Law C and McKechnie K (1997) A three-state receptor model of agonist action. Trends Pharmacol Sci 18:355-362.
17. Mackay D (1981) An analysis of functional antagonism and synergism. Br J Pharmacol 73:127-134.
18. McKinney M, Miller JH, Gibson VA, Nickelson L and Aksoy S (1991) Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition. Mol Pharmacol 40:1014-1022.
19. Mei L, Lai J, Yamamura HI and Roeske WR (1991) Pharmacologic comparison of selected agonists for the M1 muscarinic receptor in transfected marine fibroblast cells (B82). J Pharmacol Exp Ther 256:689-694.
20. Richards MH and van Giersbergen PL (1995) Human muscarinic receptors expressed in A9L and CHO cells: Activation by full and partial agonists. Br J Pharmacol 114:1241-1249.
21. Ringdahl B, Ehlert FJ and Jenden DJ (1982) Muscarinic activity and receptor binding of the enantiomers of aceclidine and its methiodide. Mol Pharmacol 21:594-599.
22. Roszkowski AP (1961) An unusual type of sympathetic ganglionic stimulant. J Pharmcol Exp Ther 132:156-170.
23. Schwartz RD, Davis RE, Jaen JC, Spencer CJ, Tecle H and Thomas AJ (1993) Characterization of muscarinic agonists in recombinant cell lines. Life Sci 52:465-472.